MedTrace Logo

Efficacy and Tolerability of the Use of Varicell Compared With Daflon

NCT01321619 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2011-06-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and tolerability of Varicell compared to Daflon, in reducing the symptoms caused by chronic venous insufficiency and hemorrhoidal syndrome.

Conditions

Interventions

DRUG

Daflon

Drug B (Daflon): Administered one tablet two times daily (oral), the main meals (breakfast and dinner)for 30 days.

DRUG

Varicell placebo

Drug C (Varicell placebo) : Administered one tablet three times a day,(oral), the main meals (breakfast, lunch and dinner)for 30 days.

Sponsors & Collaborators

  • Vidfarma Indústria de Medicamentos Ltda.

    lead INDUSTRY

Principal Investigators

  • Jacques Waisberg, Investigator · ABC School of Medicine

  • Walter Campos Júnior, Investigator · Edmundo Vasconcelos Hospital Teacher

  • Laércio Robles, Investigator · Santa Marcelina Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01321619 on ClinicalTrials.gov